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With laboratories seeking to expand analytical capabilities and create multi-class, multi-analyte
methods, there has been a shift toward generic sample clean-up techniques such as “dilute-and-shoot”.
Advantages of this methodology include its simplicity, minimal analyte losses, high sample throughput
and number of analyte classes included. The evolution of dilute-and-shoot has permitted its use across a
variety of matrices including food and biological and in various scientific fields such as food, forensics
and environmental. The versatility of the technique permits the expansion of current fields of research
without the usual laborious method development. There can be issues with matrix effects and robust
quantitation as analyte number increases. This review provides an overview of the technique combined
with liquid chromatography mass spectrometry, highlighting its power in facilitating multi-class anal-
ysis. Coupled with increases in instrument performance there is potential to employ this methodology in
expanding analytical capabilities in many areas of life science research.
© 2021 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In analytical chemistry and in particular in the field of small
molecule analysis (approx.< 1200 Da) using liquid chromatography
mass spectrometry (LC-MS), the use of “dilute-and-shoot” has
gained much traction over the last ten to fifteen years, with it now
employed in many types of multi-residue LC-MS analysis [1]. The
term itself appears quite self-explanatory, referring simply to:
“Dilution of a sample or sample extract before ‘shooting’ into an
analytical instrument for analysis.”
As a stand-alone methodology, the term implies that this
technique is the only clean-up step used before sample analysis.
However, dilute-and-shoot (DnS) is sometimes performed after an
initial deproteinisation step dependent on the matrix being
assayed, with it stated that the protein precipitation step is
considered a clean-up process [2]. If this is the case and deprotei-
nisation is carried out before dilution of the sample (supernatant),B.V. This is an open access article uif could be argued that such methodology cannot be considered
DnS. Furthermore, matrices that are not liquid must first undergo
an extraction step to facilitate movement of analytes from the
matrix to a liquid phase before dilution and analysis on some form
of mass analyser. These include matrices such as animal feed, tis-
sues and various (solid) foodstuffs. In these cases, a suitable
extraction solvent must be chosen to facilitatemigration of analytes
from a solid to a liquid phasewhich is then diluted prior to analysis.
One such example is in the recent study conducted by Sulyok et al.
(2020) measuring over 500 secondary microbial metabolites in
various food matrices using DnS coupled to LC-MS/MS [3]. Therein
lies the issue as to what extent a sample clean-up method can be
truly classified as DnS. With many publications claiming use of the
‘dilute-and-shoot’ approach but which include additional steps
such as solid-liquid extraction or deproteinisation, the use of or
definition of the technique appears to have evolved. Therefore, due
to the evolution of the technique in the literature over the last
decade, we have expounded on the simple definition stated above
to include solid matrices.
“The direct dilution of a sample or dilution of a sample extract
before ‘shooting’ into an MS platform for analysis. This also al-
lows for the addition of a solvent to a solid matrix to extractnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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dilution and analysis. Filtration and centrifugation are included
in our definition, as they are physical methods that remove solid
materials from liquid samples, therebymaking the sample more
suitable for LC-MS analyses”.
In using DnS as a sample clean-up technique, the main purpose
of the dilution step is to reduce matrix components which can
interfere with the chromatography and ionisation of the target
analytes, thereby facilitating greater sensitivity or performance of
the analytical method.With that in mind, the dilution factor used is
dictated by many factors including; concentration of the analytes
expected, the matrix analysed, the selectivity and sensitivity of the
MS platform utilised and whether the analysis is quantitative or
qualitative, with dilution factors typically ranging from 1:1 up to
1:100. Some examples include a dilution factor of 1:1 (v:v) in the
analysis of secondary microbial metabolites in food matrices; a
dilution factor of 1:10 analysing metabolites of the mycotoxins
deoxynivalenol (DON) and zearalenone (ZEN) in human urine; a
dilution factor of 1:50 in the analysis of drugs-of-abuse (DoA) and
performance enhancing drugs in human urine; a 1:100 dilution of
samples in the analysis of prosthesis-related metals in whole blood
[3e6]. One caveat of the last two examples is that the analysis of
DoA by Alcantara-Duran et al. (2018) employed nanoflow LC
coupled to an Orbitrap MS which improved method sensitivity and
permitted a high dilution factor, whereas the study by Bolea-
Fernandez et al. (2016) was of prosthesis-related metals, i.e. ele-
ments as opposed to intact molecules andwhich was carried out on
Inductively Coupled Plasma MS (ICP-MS). In the main and for the
purpose of this review, the focus will be on the analysis of small
molecules by way of LC-MS.
Over recent years there has been a shift from single class
methods with low analyte numbers toward multi-class, multi-
analyte methods. This has been achieved by moving away from
use of traditional sample clean-up techniques such as solid phase
extraction (SPE) and Immunoaffinity Columns (IAC) to more
generic techniques such as QuEChERs (Quick, Easy, Cheap, Effec-
tive, Rugged and Safe), with the latter methodology routinely
applied in multi-residue pesticide analysis in agricultural com-
modities [7]. However, even techniques such as QuEChERs still
suffer from losses or incomplete recovery of the target analytes
when performing multi-class analysis. These analyses typically
utilise chromatographic separation to aid detection and can be
performed on high performance liquid chromatography (HPLC).
Currently however, chromatography is routinely performed on
ultra-high performance liquid chromatography (UHPLC or UPLC)
coupled to some form of mass analyser. The switch to UHPLC
facilitated shorter run times while allowing the same number of
analytes to be resolved. Of late, method run times have become
longer to facilitate the increase in the number of analytes included
in a single run [3,8]. In regards to the mass analyser used, these
include low resolution mass spectrometers (LRMS), mainly triple
quadrupole instruments (QqQ or MS/MS), and high-resolution
instruments such as ion trap or orbital ion traps (Orbitrap),
time-of-flight (TOF) and the new generation of hybrid systems
such as quadrupole-ToF (QToF) and quadrupole-Orbitrap (Q-
Orbitrap), with these HRMS systems offering different resolving
powers and therefore selectivities and sensitivities. LRMS in-
struments are used mainly in routine testing laboratories for high
throughput quantitative analysis, whereas HRMS systems are
more typically employed for research purposes. Thus, the instru-
mentation used will be dependent on the type of analysis
required, whether it be fully quantitative, qualitative for screening
purposes or simply untargeted for “omics” analysis.2
The purpose of this review is to highlight the evolution in the
use of dilute-and-shoot in analytical chemistry which has now
been employed across many different matrices, whilst also indi-
cating that the definition of the term should be extended to reflect
this. In addition, we look at how its use is expanding particularly in
the area of targeted analysis, mainly due to the advancement of the
detection platforms which has allowed it to transcend many
different scientific disciplines.
2. Dilute-and-Shoot
2.1. An overview of the technique
DnS refers to the dilution of a sample matrix with a suitable
dilution solvent (diluent) for analysis. Therefore, depending on the
matrix analysed it can either be a straightforward dilution of a
biological fluid such as urine or oral fluid which conform to the
‘original’ definition of the technique. However, other more complex
fluids such as serum, plasma or milk can require an initial protein
precipitation step, or dilution of the extraction solvent used in
extracting analytes of interest from a solid matrix such as food-
stuffs, with the latter in particular included in the extended,
updated definition of the technique outlined above. Comparedwith
other traditional sample clean-up techniques which remove un-
wanted co-extracted matrix components, DnS simply decreases
matrix effects while eliminating time-consuming and expensive
extraction procedures and can therefore be considered the most
straightforward and fastest clean-up method available. One caveat
of this is in the application to solid foodstuffs whereby an extraction
step is required to facilitate migration of analytes from a solid to a
liquid phase, with examples detailed in Table 1.
Use of DnS in analytical chemistry has become quite common-
place due to its simplicity, limited and fast sample preparation, low
solvent usage and associated low-costs, as well as reduced waste
production, with the benefit of being more environmentally
friendly than most other sample clean-up techniques. As well as
being a relatively environmentally friendly technique, DnS lends
itself well to high throughput routine analysis which has led to its
use across various disciplines such as in drugs-of-abuse (DoA) and
anti-doping (performance enhancing drugs), forensics and food
safety, and can be used across a range of “omics” studies such as
metabolomics. It also lends itself to multi-class, multi-analyte ap-
proaches as there are little to no analyte losses and its simplicity
minimises the chance of errors during the extraction stage. How-
ever, there can be issues with the repeatability, reproducibility,
accuracy and precision of this technique, especially in relation to
the validation of multi-residue methods in foodstuffs using DnS.
These aforementioned issues have been addressed somewhat in
the studies carried out by Malachova et al. (2015) and Sulyok et al.
(2020) [3,9]. Examples of where the DnS methodology has been
employed alongside either LC-MS/MS or LC-HRMS are given in
Table 1, with examples as to why DnS is such a powerful analytical
tool is discussed in more detail later.
2.2. Issues with dilute-and-shoot: terminology and methodology
In terms of the expounded definition of DnS, whereby an
extraction solvent is required to facilitate the migration of analytes
from a solid matrix into a liquid phase before dilution for analysis,
one must be aware that the choice of extraction solvent directly
impacts the range of analytes that can be extracted, i.e. the polarity
of the extraction solvent used will determine the polarity and
therefore range of analytes extracted. It is clear that certain
matrices require an extraction step before dilution and an example
of this is addressed in the study by Sulyok et al. (2020). The
Table 1
Application of dilute-and-shoot alongside LC-MS/MS across various scientific disciplines and sample matrices.
Compound type (number of
analytes)
Matrices Methodology LC-MS Platform Analytical conditions Reference
Mycotoxins (39) Wheat & maize 0.5 g matrix extracted with 2 mL of extraction
solvent (ACN:H2O:CH3COOH, 79:20:1 v/v/v),




with a Turbo Ion Spray ESI
source (AB SCIEX) coupled
to a 1100 series HPLC
(Agilent)
ESIþ & ESI: MRM
Gemini C18 column (150 mm  4.6 mm,
5 mm) þ C18 security guard cartridge
(4 mm  3 mm, 5 mm) @ 25C, flow rate 1 mL/
min, injection volume 5 mL.
MPA: MeOH:H2O:CH3COOH (10:89:1 v/v/v),







maize & green pepper
0.5 g matrix extracted with 2 mL of extraction
solvent (ACN:H2O:CH3COOH, 79:20:1 v/v/v).




with a TurboV ESI source
(AB SCIEX) coupled to a
1290 series UHPLC (Agilent)
ESIþ & ESI: sSRM
Gemini C18 column (150 mm  4.6 mm,
5 mm) þ Gemini C18 guard column
(4 mm  3 mm, 5 mm) @ 25C, flow rate 1 mL/
min, injection volume 5 mL.
MPA: MeOH:H2O:CH3COOH (10:89:1 v/v/v),






Wheat, maize, figs, dried
grapes, walnuts, pistachios
& almonds.
0.25 g matrix extracted with 1 mL of extraction
solvent (ACN:H2O:CH3COOH, 79:20:1 v/v/v).




with a TurboV ESI source
(AB SCIEX) coupled to a
1290 series UHPLC (Agilent)
ESIþ & ESI: sMRM
NB: Two separate runs for
ESIþ & ESI
Gemini C18 column (150 mm  4.6 mm,
5 mm) þ C18 security guard cartridge (4  3 mm
i.d.) @ 25C, flow rate 1 mL/min, injection
volume 5 mL.
MPA: MeOH:H2O:CH3COOH (10:89:1 v/v/v)






Rice 5 g of rice was extracted and diluted with 10 mL
ACN:H2O (8:2 v/v) containing 2% CH3COOH (v/
v) then filtered.
Dilution factor 1:3
QTRAP® 6500 (AB SCIEX)
coupled to a 1290 series
UHPLC (Agilent)
ESIþ & ESI: MRM
Zorbax RRHD C18 column (50 mm  2.1 mm,
3 mm) with pre-column @ 30C, flow rate
350 mL/min, injection volume 5 mL.





Wine (red) A 500 mL aliquot of wine was diluted with
500 mL of MeOH:ACN (1:1, v/v) and filtered.
Dilution factor 1:2
Xevo® TQ-S (Waters)





ACQUITY UPLC® BEH C18 column
(100 mm  2.1 mm, 1.7 mm) @ 60C, flow rate
450 mL/min.
Pesticide analysis:
MPA: 5 mM NH4HCOO (aq), MPB: MeOH
Mycotoxin analysis:
MPA: H2O and MPB: ACN, both containing 0.1%
HCOOH (v/v)
[17]
Prescription drugs, DoA and
metabolites (37)
Urine (human) 100 mL of centrifuged urine diluted with
700 mL H2O and 200 mL ISmix.
Dilution factor 1:10
TQ-S Micro (Waters)
coupled to an ACQUITY
UPLC (Waters)
ESIþ: MRM
CORTECS C18 column (2.1 mm 50mm, 1.6 mm)
@ 30C.
NB: Injection volume not stated.





Urine (human) 100 mL of centrifuged urine diluted with 900 mL
of diluent (H2O:ACN:HCOOH, 94:5.:1 v/v/v)
Dilution factor 1:10
QTRAP® 6500 (AB SCIEX)
coupled to a 1260 Infinity
series HPLC (Agilent)
ESIþ & ESI: sMRM
NUCLEODUR® C18 Pyramid column
(150 mm  2 mm, 3 mm) with a C18 guard
column (2 mm  4 mm), flow rate 600 mL/min,
injection volume 10 mL.
MPA: ACN, MPB: Water (both containing 0.1%
HCOOH v/v).
[70]
Statins (8) Urine (human) 500 mL of urine spiked with 60 mL ISmix and
made up to 1.5 mL total volume with H2O.
Dilution factor 1:3
API 3200 Q-Trap equipped
with a Turbo V ESI source
(AB SCIEX) coupled to an
Agilent 1200 series.
ESIþ: MRM
Kinetex C18 column (50 mm  3.0 mm, 2.6 mm)
with a C18 guard column (4 mm  3 mm) @
20C, flow rate 350 mL/min, injection volume
10 mL.
MPA: Water (0.1% CH3COOH), MPB: ACN.
[92]

















Table 1 (continued )
Compound type (number of
analytes)
Matrices Methodology LC-MS Platform Analyti onditions Reference
Neurotransmitters and
metabolites (10)
Urine (human) Dilute 1 mL of urine with 1 mL of ACN. Mix,
centrifuge then dilute 1 mL supernatant with
0.25 mL ISmix and 1.25 mL 0.2 M acetic acid.
Dilution factor 1:5
6490 TQ MS (Agilent)
coupled to a 1290 infinity
series LC system (Agilent)
ESIþ: MRM
Agilent oshell 120 Bonus-RP LC column
(2.1 mm 100 mm, 2.7 mm), flow rate 180 mL/
min.
NB: Inj n volume not stated.
MPA: W r (0.2% HCOOH, v/v).MPB: ACN (0.1%
HCOOH ).
[31]




(iii) Mycotoxins DON, ZEN
and metabolites
NB: All of the above studies
use the same extraction
and analysis.
Urine (human) Dilute 100 mL of centrifuged urine with 900 mL
dilution solvent (H2O:ACN, 90:10 v/v).
Dilution factor 1:10
QTRAP® 5500 equipped
with a Turbo V ESI source
(AB SCIEX) coupled to a
1290 series UHPLC (Agilent)
ESIþ & ESI: SRM
Atlantis 3 column (150 mm  3 mm, 3 mm)
with a ecurity guard cartridge @ 35C, flow
rate 60 /min, injection volume 5 mL.
MPA: W r, MPB: ACN (both containing 0.1%
CH3COO
[4,10,11]
ZEN and metabolites (9*)
*known metabolites
Urine (porcine) Urine samples diluted to 0.2 mM creatinine
with H2O then centrifuged.
Dilution factor unknown
QTRAP® 6500 equipped
with an Ion Drive Turbo V
ESI source (AB SCIEX)
coupled to a 1290 series
UHPLC (Agilent)
ESI: SRM
Kinetex henyl column (150 mm  3 mm,
2.6 mm 0C, flow rate 400 mL/min, injection
volume L.





Urine (human) 100 mL of urine spiked with ISmix and diluted
with 400 mL H2O.
Dilution factor 1:5
Enzymatic hydrolysis:
100 mL of urine mixed with 100 mL
glucuronidase solution.
Dilution factor 1:2
Agilent 6460 QqQ MS with
Jet
Streaming Technology
coupled to a 1290 Infinity
series LC (Agilent)
ESIþ: dMRM
Zorbax HD Eclipse Plus C18 column
(100 m 3 mm, 1.8 mm) with pre-column @
40C, fl rate 300 mL/min, injection volume
5 mL.
MPA: 5 NH4HCOO (aq) (0.1% HCOOH, v/v),




Urine (human) 500 mL of urine mixed with 500 mL of H2O.
Dilution factor 1:2
QTRAP® 4000 (AB SCIEX)
coupled to an Ultimate
3000 LC (Dionex)
ESIþ & ESI: MRM
Acclaim 0C18 column (150 mm  2.1 mm,
2.2 mm 0C, flow rate 450 mL/min, injection
volume mL.





Oral fluid, serum and urine
(human)
100 mL of sample mixed with 100 mL M3®




coupled to an ACQUITY
UPLC® I-class (Waters)
ESIþ: MRM
ACQUIT PLC® BEH C18 column
(50 mm 2.1 mm, 1.7 mm) @ 50C, flow rate
400 mL/ , injection volume 10 mL.
MPA:W r containing 50mMNH4HCOO pH3,
MPB: M
[73]
Psychoactive drugs (13) Oral fluid (human) 500 mL of oral fluid was mixed with 10 mL ISmix
and diluted further with 1 mL H2O.
Dilution factor 1:3
Xevo® TQ-S (Waters)
coupled to an ACQUITY
UPLC® I-class (Waters)
ESIþ: MRM
ACQUIT PLC® BEH C18 column
(75 mm 2.1 mm, 1.7 mm) @ 50C, flow rate of
350 mL/ , injection volume 2 mL.
MPA: W r, MPB: ACN (both containing 0.1%
HCOOH
[15]
Broad spectrum drugs of
abuse (61)
Urine (human) 200 mL aliquot of urine diluted with 400 mL H2O,
300 mL b-Glucuronidase solution and 100 mL
ISmix.
Dilution factor 1:2
Xevo® G2 ToF (Waters)
coupled to an ACQUITY
UPLC (Waters)
ESIþ
Resolution: 20 000 FWHM@
m/z 400
Mass tolerance: ±5 and
20 ppm
ACQUIT PLC® BEH C18 column
(150 m 2.1 mm, 1.7 mm) @ 50C, flow rate
400 mL/ , injection volume 20 mL.
MPA: 5 NH4HCOO(aq) (pH 3), MPB: ACN


































































to an Accela 1250 LC
(Thermo Scientific)
ESIþ & ESI
Resolution: 50 000 FWHM@
m/z 100 to 2000
Mass tolerance: ±5 ppm
Varian Omnispher™ C18 column
(100 mm  2 mm, 3 mm) þ ChromSep guard
column (10 mm  2 mm, 5 mm) @ 35C, flow
rate 250 mL/min, injection volume 25 mL.
MPA: H2O and MPB: MeOH, both containing




Urine (human) 270 mL aliquot of urine diluted with 100 mL of




Orbitrap® coupled to an
Accela LC (Thermo
Scientific) and a 1100 series
LC (Agilent)
ESIþ & ESI
Resolution: 17 500 FWHM@
m/z 100e500 Da
Mass tolerance: ±5 ppm
Nucleodur HILIC column (100 mm  2 mm,
1.8 mm) þ Nucleodur HILIC trapping column
(20 mm  2 mm, 3 mm), flow rate 250 mL/min,
injection volume 20 mL.
MPA: H2O, MPB: ACN and MPC: 200 mM
NH4CH3COO(aq) (0.15% glacial CH3COOH, v/v)
[95]
Sport drugs (46) Urine and plasma (equine) Plasma: 75 mL aliquot of deproteinated plasma
diluted with 75 mL MPA.
Dilution factor 1:3
Urine: 20 mL aliquot spiked with 20 mL ISmix and




to an ACQUITY UPLC®
(Waters)
ESIþ
Resolution: 140 00 FWHM@
m/z 200
Mass tolerance: ±5 ppm
ACQUITY UPLC® BEH C18 column
(100 mm  2.1 mm, 1.7 mm) @ 55C, flow rate
350 mL/min, injection volume 5 mL.





Meat (beef, pork & chicken) 2.5 mL of H2O added to 2.5 g of homogenised





to a Transcend 600 UHPLC
(Thermo Scientific)
ESIþ & ESI
Resolution: 25 000 FWHM@
m/z 70 to 1000
Mass tolerance: ±5 ppm
Hypersil GOLD aQ C18 column
(100 mm  2.1 mm, 1.7 mm) @ 30C, flow rate
300 mL/min, injection volume 10 mL.
MPA: 4 mM NH4HCOO (aq) (0.1% HCOOH, v/v),






Tea (brew and leaves) Tea brew: 2 mL diluted with 8 mL H2O:ACN
(3:1, v/v) acidified with 0.1% HCOOH (v/v) then
0.5 mL of the mixture filtered (0.2 mm).
Dilution factor 1:5
Tea leaves underwent a “dilute, shoot& evaporate
approach”.
Xevo® G2-S ToF (Waters)





Resolution: 30 000 FWHM@
m/z 200
Mass tolerance: not given
C18 PFP column (150 mm  2.1 mm, 2 mm) @
30C, flow rate 400 mL/min, injection volume
10 mL.
MPA: H2O, MPB: ACN both containing 0.1%
HCOOH (v/v) and MPC: MeOH
[97]









Resolution: 70 000 FWHM@
m/z 195
EASY-Spray PepMap® C18 column
(150 mm  75 mm, 3 mm) @ 25C, flow rate
200 nL/min, injection volume 1 mL.
MPA: H2O, MPB: ACN both containing 0.1%
HCOOH (v/v)
NB: Nano-flow used as opposed to LC
[5]
ACN: Acetonitrile, CH3COOH: Acetic acid, DoA: Drugs of Abuse, DON: Deoxynivalenol, dMRM: Dynamic Multiple Reaction Monitoring, ESI: Electrospray Ionisation, ESI-: Electrospray Ionisation (negative mode), ESIþ: Electrospray
Ionisation (positive mode), FWHM: Full Width at Half Maximum (resolution), HCOOH: Formic acid, HILIC: Hydrophilic Interaction Liquid Chromatography, HPLC: High Performance Liquid Chromatography, ISmix: Internal
Standard mixture, LC: Liquid Chromatography,MeOH: Methanol, MPA: Mobile Phase A,MPB: Mobile Phase B,MPC: Mobile Phase C,MRM: Multiple Reaction Monitoring,MS: Mass Spectrometry, MS/MS: Triple Quadrupole Mass
Spectrometry (QqQ),m/z:Mass to Charge Ratio, NH4CH3COO: Ammonium acetate, NH4HCOO: Ammonium formate, ppm: Parts Per Million, QTRAP®: Triple Quadrupole Linear Ion Trap, QuEChERS: Quick, Easy, Cheap, Effective,
Rugged, and Safe, sMRM: Scheduled Multiple Reaction Monitoring, SPE: Solid Phase Extraction, SRM: Selected Reaction Monitoring, UHPLC: Ultra-High Performance Liquid Chromatography, UPLC®: Ultra-Performance Liquid
Chromatography, ZEN: Zearalenone.

















Fig. 1. Example of the best practice workflows across different matrices such as foodstuffs (solid and liquid) and biological for both quantitative and qualitative (screening) analysis
using LC-MS (MS/MS or HRMS). 1Dilute and shoot approach; 2Dilute, evaporate and shoot approach; *Store in darkness overnight to allow solvent evaporation and analyte
interaction with matrix; *Representative solvent; ISmix: Internal standard mix.
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DnS is a good example of the ambiguity of the classic DnS defini-
tion. In this study, the authors looked at several food matrices with
varying degrees of complexity, from wheat and maize to several
classes of nuts. A 250 mg aliquot was extracted with 1 mL of
extraction solvent and after mixing and centrifugation, a 300 mL
aliquot of supernatant was diluted 1:1 (v/v) with dilution solvent
giving a dilution factor of 1:2, after which a portionwas injected for
analysis. Compare this to the DnS protocol employed byWarth et al.
(2012) whereby a 100 mL aliquot of sample matrix, in this case
human urine, was simply diluted with 900 mL of dilution solvent
after centrifugation, giving a dilution factor of 1:10 before analysis
[10,11]. Although both methods employ sample dilution, the
simplicity of the latter leans more toward the type of application
that fits with the DnS concept, i.e. no other extraction or sample
clean-up technique was used, with the key differences outlined in
the workflows shown in Fig. 1. There are also publications that
mention use of DnS as their clean-up approach, however on ex-
amination of the methodology employed, some have used an
additional clean-up step to reduce matrix interferences further
including QuEChERS or SPE and are therefore not DnS [12e14].
A potentiallymore rigorous definition of DnS is that it is the only
technique used prior to analysis by LC-MS, thus the technique only
really applies to liquid matrices such as urine, oral fluids and liquid
foodstuffs such as winewhich can simply be diluted before analysis
[4,5,11,15e17]. However, as outlined above, the definition must be
extended to include dilution of a sample extract such as that per-
formed in the study by Sulyok et al. (2020). Furthermore, other
biological matrices such as blood (whole blood, serum or plasma)
must first undergo a step to facilitate removal of proteins due to the
fact they can block the column, injector and/or components of the
LC system. This protein precipitation step is typically performed by
addition of an organic solvent such as acetonitrile, methanol,6
ethanol or acetonewhich precipitates the protein content as well as
partitioning the analytes of interest from the matrix into the
organic solvent layer. However, this protein precipitation step can
be considered an additional clean-up process. After deproteinisa-
tion and centrifugation, an aliquot of supernatant is diluted for
analysis, or no further dilution is performed due to the solvent
volume added at the protein precipitation step being sufficient.
Therefore, in this case we have to extend the definition of DnS to
include this additional step. Examples of this methodology include
the analysis of pesticides and carotenoids in human serum using
HPLC-DAD and HPLC-MS/MS respectively [18,19].
However, use of DnS can be problematic for detection of blood
metabolites found in low concentrations, due to the dilution caused
by addition of solvent required for deproteinisation. This can be
remedied by drying the supernatant under a gentle stream of ni-
trogen before reconstitution in an appropriate volume to facilitate
detection of lower concentration metabolites. This technique has
been referred to as a ‘dilute, evaporate and shoot’ approach [20].
One such example of this methodology was employed in the study
by Devreese et al. (2012) in the analysis of pig plasma for myco-
toxins and metabolites and which is routinely employed in this
type of analysis [20e23]. One note of caution in this methodology is
that the drying step can lead to some loss of analytes, particularly in
complex matrices such as blood. Therefore, this methodology does
not fall under the expounded DnS definition, and as such should be
termed ‘dilute, evaporate and shoot’.
2.3. Instrumentation: low resolution (LRMS/QqQ) versus high
resolution mass spectrometry (HRMS)
The lack of selectivity associated with DnS is due to its generic
sample clean-up and this can be offset by the selectivity afforded by
triple quadrupole (QqQ) mass spectrometers that generally afford
B. Greer, O. Chevallier, B. Quinn et al. Trends in Analytical Chemistry 141 (2021) 116284higher sensitivity than HRMS systems. There are many MS in-
struments on the market compatible with HPLC/UHPLC and which
have been comprehensively reviewed in relation to their suitability
for the intended analytical method [24e26]. As shown in Table 1
whereby DnS was employed alongside LC-MS/MS, the majority of
analysts used an AB SCIEX QTRAP [27e29]. With DnS diluting
rather than removing matrix, as well as diluting the analytes of
interest therein, these systems appear to reduce the influence of co-
eluting matrix compounds and offer better sensitivity due to the
enhanced selectivity afforded by the QTRAP technology and source
design. This is not to state that these are the only QqQ instruments
capable of being used alongside DnS, with other QqQ instruments
also used successfully alongside DnS such as the Waters Xevo TQ-
XS and Agilent 6460 and 6490 Triple Quadrupole LC-MS systems
[15,17,30,31].
With improvements in QqQ instrumentation electronics facili-
tating faster cycle and dwell times, the number of analytes that can
be included in a single run can be increased. One example of this is
in the analysis conducted by Sulyok et al. (2020) in which more
than 500 secondarymicrobial metabolites were analysed in a single
run using a QTRAP 5500 (AB SCIEX), with chromatography per-
formed on HPLC as opposed to UHPLC resulting in a run time of
approximately 20 min. One caveat of this method and others with
multiple analytes such as that of Steiner et al. (2020), is that with
increasing analyte number and subsequent MRM transitions, cycle
and dwell times have to be reduced in order to acquire enough data
points per analyte for robust quantitation. Further to this, although
polarity switching can be performed as rapidly as 5 msec according
to some vendors, this along with the settling time would be
detrimental to the number of data points acquired at any given
time, and therefore, two injectionsmay be required. Another multi-
analyte method was that conducted by Kimble and DeCaprio
(2019), analysing more than 800 psychoactive substances using an
Agilent 6460 MS/MS with Jet Streaming Technology coupled to
UHPLC. As with the aforementioned methods, due to the dwell and
cycle times afforded by the instrument, the actual number of ana-
lytes in a single runwas approximately 400, with samples analysed
twice to cover all 800-plus compounds. The analysis time for each
run was 20 min and therefore 40 min overall [30]. Thus, due to the
enhanced selectivity and stability afforded by QqQ platforms, these
instruments are generally used for quantitative analysis.
A new generation of hybrid HRMS systems has improved their
capabilities, such as the quadrupole-ToF (QToF) and quadrupole-
Orbital ion trap and which can now compete with QqQ in-
struments. These latest HRMS instruments have significantly better
sensitivity specifications than previous HRMS instruments, ach-
ieved by advances in detection technology and increased resolving
power, ultimately leading to a reduction in interferences with
matrix compounds. The addition of the quadrupole (Q) to these
instruments allows them to perform both qualitatively and quan-
titatively, with one such study using one of the new generation
hybrid HRMS systems carried out by Martinez-Dominguez et al.
(2016). In this multi-class, multi-analytemethod, they analysed 257
pesticides and mycotoxins using a Q-Exactive Orbitrap both quali-
tatively and quantitatively. Although their methodology included
an extra clean-up step after performing DnS, by way of florisil SPE
cartridges, they reported similar results for DnS alone and only
added SPE to maintain instrument performance [13].
One drawback in the use of QToF analysers is that polarity
switching is not possible or practical and although this can be
achieved with an Orbitrap, it is offset by a reduction in the in-
struments resolving power. However, with use of UHPLC as
opposed to HPLC providing faster run times, this allows injection of
each sample in positive and negative ion modes with the benefit
that ionisation can be optimised for both, therefore increasing the7
number of detected compounds [32]. Overall, the number of
methods employing DnS alongside LC-MS/MS compared to LC-
HRMS over the last 10 years is higher as indicated in the number
of examples shown in Table 1. One thing to note is that not all ar-
ticles using the DnS approachmention themethodology in the title,
abstract or keywords. Therefore, the number of publications
employing the technique are higher than indicated when a litera-
ture search is performed with the keywords ‘DnS’ combined with
either ‘tandem MS’, ‘high resolution MS’ or ‘Orbitrap’. Use of QqQ
over HRMS is in part due to the enhanced selectivity afforded by
QqQ instruments as well as their sensitivity which compensate for
the generic sample clean-up technique. With the matrix being
reduced rather than removed, the selectivity of QqQ instruments
allows analytes to be identified based on the differentiation be-
tween analyte and unwanted matrix, although this is also due to
the sensitivity as selectivity alone does not afford adequate detec-
tion limits. However, with many of the technical limitations around
HRMS instruments having been resolved with advancements in
technology, as well as the introduction of the hybrid quadrupole
HRMS systems, there may well be a rise in the number of analysts
using HRMS for routine laboratory tests.
3. Matrix effects
In order to extract analytes from a liquid food matrix or bio-
logical matrices such as urine or blood, liquid-liquid extraction
(LLE) can be used. Alternatively, solid-liquid extraction is used on
solid matrices such as feed and food. In either case, the process
using a single or multiple component liquid extraction mixture
(organic solvents, water, acids, bases, etc.) serves to migrate the
analytes of interest from the matrix into the added liquid phase.
The addition of water to the organic (extraction) solvent can help
the organic solvent penetrate the food matrix in the case of solid
foodstuffs, while also facilitating extraction of some of the more
polar analytes. The addition of acid serves to help break bonds
between the analytes and some of the matrix components such as
proteins and sugars, aiding their extraction [33]. When an extrac-
tion technique is chosen, there will always be co-extraction of
matrix components giving rise to matrix effects, with the amount
dependent on the extraction solvent and complexity of the sample.
Some of the most challenging issues in analytical chemistry are
matrix effects caused by co-extracted matrix compounds. These are
unpredictable and can cause various issues such as: ion suppression
(or in some cases enhancement), poor chromatography, false pos-
itives due to the presence of isobaric compounds, poor analyte
recovery due to chemisorption and interferences with the ion ratio
of the product ions in targeted analysis [34,35]. Use of internal
standards is one of the most commonly used ways to compensate
for matrix effects, however, as various analytes can exhibit different
behaviours in the same matrix, ideally an internal standard is
required for each analyte. This is not feasible due to the fact they are
expensive and also that commercial availability is limited. Standard
addition is another way to compensate for matrix effects and is
often used in routine analysis. However, it is more suited to single-
analyte methods rather than multiple-analyte determination due
to it being laborious and costly because of its high consumption of
standards [1]. Some of these issues can be overcome by improved
chromatography, however, this has limitations as there has to be a
benefit of improved chromatography against the need for fast run
times, especially in high-throughput laboratories.
Evenwith the advancement in detection capabilities afforded by
LC-MS, there may still be a need for sample clean-up to remove
unwanted matrix compounds using more traditional techniques
such as SPE, IACs, LLE or QuEChERS when method sensitivity is
paramount [26]. Use of these techniques is really only applicable for
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be assessed. This has limitations in regards to the number of ana-
lytes that can be incorporated and can get difficult as the number of
analytes increase due to several factors, which include but are not
limited to: Differing physiochemical properties, selectivity/speci-
ficity of the clean-up technique, instability of some analytes in the
working standard solution, ionisation efficiency, availability of
reference material and suitability of the clean-up platform chosen.
An example of some of the issues encountered when employing
DnS for a multi-class, multi-analyte method was highlighted in the
study conducted by Malachova et al. (2014), with validation data
acquired for 295 of the 331 target analytes due to some of the
aforementioned issues. One of the main issues was that of signal
suppression/enhancement (SSE) due to matrix effects and which
was observed for all four matrices studied. Green pepper was
considered the most complex matrix of the four, with only 10% of
analytes not suffering from SSE [28]. In this example, samples were
run in both positive (ESIþ) and negative ionisation modes (ESI). A
recent study by Steiner et al. (2020) investigated matrix effects of
80 fungal metabolites, 11 pesticides, and 9 pharmaceutical active
agents in complex feed using DnS and LC-MS/MS. Although the
majority suffered signal suppression, with polar analytes in ESIþ
particularly susceptible to this, apolar analytes in ESI were prone
to signal enhancement, both caused by co-extracted matrix com-
pounds [8].
Other matrices such as black tea (highly complex and dry) and
rocket (high water and chlorophyll content) have shown to be
somewhat problematic in pesticide analysis (39) using dilution of a
sample extract [36]. Black tea and rocket indicated that only 4% and
7% of the analytes respectively were free of matrix effects at a 10-
fold dilution, whereas the majority were completely free of ma-
trix effects at a 100-fold dilution, indicating that a “dilute-and-
shoot” approach may be successful. However, depending on the
concentration of analyte(s) present, this dilution factor may prove
too much for analyte detection. Therefore, a compromise could be
sought, with a 25-fold dilution proving suffice if matrix effects were
no greater than 20%. Another pesticide study in fruit and vegetables
indicated that with no dilution, the matrices varied in the percent
of analytes showing no suppression, defined as being <20%. Leek
proved the most problematic, with only 9% of pesticides not
supressed and 37% of analytes highly supressed (>50%). Overall, a
dilution factor of 15-fold was enough to eliminate matrix effects,
permitting quantification with solvent standards for the majority
[37]. Therefore, matrix effects and analytical sensitivity will be a
major factor in whether DnS can be employed, as well as the
number and classes of analytes to be incorporated in themethod. In
some instances, the complexity of the sample matrix can lead to
severe matrix effects and depending on the sensitivity required,
DnS may not be suitable and other sample clean-up strategies may
need to be employed, such as those listed in section 4.
Taking into account complex matrices such as black tea, rocket,
leek and green pepper, as well as other matrices studied such as
urine and foodstuffs, all of the aforementioned can lead to signal
suppression of the analytes therein, caused by co-elution of un-
wanted matrix components and the resulting contamination of the
MS source and ion optics. Thus, although use of DnS can give
excellent results with little to no sample preparation, MS detectors
may well require regular venting and cleaning of the source com-
ponents after multiple injections tomaintain instrument sensitivity
leading to unwanted instrument downtime. Therefore, when using
DnS, the downtime is dependent on theMS system used and source
design, with ABSCIEX QqQ instruments appearing to be the in-
strument of choice for targeted analysis using DnS as indicated in
Table 1. Of late, there has been improvements in source designwith
various vendors implementing different designs or technologies to8
improve sensitivity while also reducing the necessity for regular
maintenance. Examples of this include differential mobility spec-
trometry (DMS) with SCIEX introducing the SelexION DMS tech-
nology and the Agilent Jet Stream Ion Source with the addition of
VacShield. These technologies serve to enhance the systems
robustness with the bonus of spending less time on maintenance
and increasing sample throughput.
4. Sample clean-up techniques to reduce matrix effects
4.1. Solid phase extraction (SPE)
SPE is a useful tool for reducing matrix effects across various
complex matrices such as foodstuffs, animal feed, aqueous samples
and other biological matrices, and usually affords low LOQs. How-
ever, a drawback in its suitability for sample clean-up is the number
of analytes incorporated is usually limited due to the selectivity of
the stationary phase, with several factors to consider when
choosing this such as: varying physiochemical properties of the
analytes and the loading, washing and elution steps which can lead
to losses or incomplete recovery of analytes. All of the aforemen-
tioned can lead to time consuming and laborious method devel-
opment. Some examples in the use of SPE include the analysis of
mycotoxins in pig serum, plasma and urine and in the analysis of
freshwater toxins in aquaculture ponds and fish tissues [38e41],
the analysis of mycotoxins in baby food, analysis of nerve agents in
human urine and the analysis of veterinary drug and pesticide
residues in animal feed [12,42,43]. Furthermore, two or more SPE
columns can be used in tandem to analyse several compound
classes, or an analyte (ZEN) and its metabolites across various
matrices [44].
4.2. Micro-extraction techniques: sorbent-based
Similar to SPE, micro-extraction techniques based on solid
phases or sorbents are now commonplace for use in sample prep-
aration and clean-up. These techniques include solid-phase
microextraction (SPME), stir-bar sorptive extraction (SBSE) and
micro-extraction by packed sorbent (MEPS) [45].
SPME is based on partitioning of analytes between a coated fibre
and sample, achieved by placing the SPME fibre above a solution
(matrix) to capture the volatile vapour. However, SPME is more
routinely employed alongside GC-MS analysing volatile organic
compounds (VOCs) or volatile metabolites (VOMs). Use of direct
immersion SPME (DI-SPME) has facilitated its compatibility with
LC-MS in the analysis of non-volatiles [46]. One main drawback is
its use of stationary phases coating the fibre [47], and along with
DI-SPME showing poor recoveries in the analysis of polar mole-
cules, the capacity of this technique in the creation of multi-class,
multi-analyte methods for analysis by LC-MS is limited. Similar to
SPME, SBSE is suited to analysis of medium to apolar molecules
across various matrices using GC-MS. When combined with a
sorptive phase, multi-residuemethods have been developed for the
analysis of endocrine disruptors (77) and pesticides (15) in water
samples using GC-MS and LC-MS respectively [48]. Analysis of polar
molecules by SBSE requires derivitisation which is laborious,
although new materials could be developed in order to directly
analyse polar molecules by LC-MS, making them comparable to SPE
cartridges [48]. Once again however, the limitations for SBSE are
similar as those mentioned for both SPME and SPE.
MEPS has been developed as aminiaturised version of SPE and is
fully compatible with LC-MS, with the added benefits of being fully
automated, rapid and reduced solvent usage in comparison to SPE.
Due to its size, MEPS are perfectly suited to small volumes of bio-
logical fluids such as plasma/serum, oral fluids and urine [45]. With
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centration of analytes therein, they concentrate the analytes of
interest whilst simultaneously removing unwanted matrix com-
pounds, giving rise to more sensitive analytical methods. However,
as with the other aforementioned techniques, the selectivity of the
sorbent limits the number of analytes incorporated.4.3. Immunoaffinity Columns (IACs)
IACs work on the basis that the stationary phase contains an
antibody to capture the analyte(s) of interest and can facilitate
analysis at low levels, generally affording low LOQs. Although IACs
are very selective, this has drawbacks such as lack of specificity for
analytes of different classes or analogues, and they can exhibit
some non-specific binding with other proteins. IACs are mainly
used in the analysis of one or two compounds due to the cross
reactivity profile of the antibody, such as in the analysis of chlor-
amphenicol in food or vitamin B12 in green algae [49,50]. IACs can
be utilised in the analysis of several compounds such as in the study
of microcystins (15) and the structurally related toxin nodularin,
with a comparison between IAC and SPE indicating a lower method
detection limit using IAC [51]. They have also been developed with
the capacity to bind several mycotoxins with varying physico-
chemical properties across a range of biological matrices, such as
the 11þ Myco MS-PREP IAC (R-Biopharm: https://food.r-biopharm.
com/products/11myco-ms-prep/). IACs can facilitate quantification
with solvent calibration curves, although this is not always the case
as some feed matrices have been shown to cause SSE evenwith use
of IACs [52]. In order to analyse a wider range of analytes, IACs with
different specificities can be used in tandem [53], and they can also
be used in conjunctionwith SPE, with themain driver in doing so to
increase analyte number [54,55]. However, the selectivity of these
techniques do not lend themselves to creation of multi-analyte
methods.4.4. QuEChERs
QuEChERs was introduced in 2003 and has rapidly expanded
from use in pesticide analysis to applications in food, pharmaceu-
tical, environmental and biological analysis. Due to its success, two
international standard organisations adopted versions of the orig-
inal technique for quantitation of pesticides in both fruit and veg-
etables; the European Committee for Standardisation (CEN) and the
Association of Official Analytical Chemists (AOAC) International
[56]. The method combines liquid extraction and partitioning using
salts, followed by a clean-up step using dispersive SPE (dSPE). As
well its simplicity, it is relatively cheap in comparison to other
techniques as well as being rapid.
QuEChERs has been used extensively in pesticide residue anal-
ysis in fruit and vegetables, with 451 pesticide residues analysed
along with a Q-Exactive Orbitrap, permitting both identification
and quantitation [7]. Work has been conducted to evolve the
method to areas other than pesticide analysis in agricultural com-
modities, with these discussed in two comprehensive reviews
looking at its evolution, applications and trends [56,57]. Suffice to
say, it is now used in the analysis of mycotoxins, antibiotics, vet-
erinary drugs and herbicides across a variety of matrices. One such
example is the analysis of 630 multi-class food contaminants using
UHPLC-QToF including, veterinary drugs, food-packaging contam-
inants andmycotoxins, although themajority were pesticides (426)
[58]. Although a very effective and evolving technique, it like other
clean-up techniques has disadvantages due to incomplete or low
recoveries of the suite of analytes due to the choice of dSPE chosen,
as well as being mainly pesticide-centric.9
4.5. Liquid-liquid extraction (LLE)
Used as an extraction technique for some liquid matrices, LLE is
considered to be a sample clean-up step. Apart from facilitating
protein precipitation in some matrices, the partitioning separates
compounds based on their solubility in two different immiscible
liquids, such as water and an organic solvent, with analytes typi-
cally extracted in the organic layer leaving matrix components in
the other, with some matrix co-extracted in the organic layer and
vice versa. Asmentioned previously, the choice of extraction solvent
dictates the polarity of the analytes extracted and therefore pre-
sented for analysis. This is particularly important for untargeted
qualitative analysis or metabolomic studies using LC-HRMS. In
general, most of these extractions are conducted on biological
matrices with examples given below.
4.5.1. LLE applied to blood samples (plasma or serum)
This involves addition of an organic solvent for both deprotei-
nisation and migration of analytes from matrix to the solvent,
which may be acidified. This technique has limited advantages due
to only partial removal of matrix components which are respon-
sible for signal suppression [21]. Furthermore, in most instances
instead of dilution, the sample is dried and reconstituted to
concentrate the analytes of interest, with the caveat that it also
concentrates any matrix present too. This technique, referred to as
‘dilute, evaporate and shoot’ has benefits similar to DnS where the
same extraction procedure can be employed for targeted and
untargeted analysis due to minimal or no analyte losses. Examples
include the studies carried out by Catteuw et al. (2019), Devreese
et al. (2012) and Lauwers et al. (2019) on pig plasma [21,22,59] and
others conducted in human plasma [60,61].
4.5.2. LLE applied to urine samples
Unlike blood, urine can simply be diluted for analysis as it does
not usually require deproteinisation. In some instances, the addi-
tion of an organic solvent is needed to facilitate migration of the
analytes from the polar, aqueous urine phase into the organic
phase, whilst removing some matrix, before drying and recon-
stituting the organic layer. Examples of this include the analysis of
mycotoxins where the urine was extracted with acetonitrile/water/
formic acid (52/45/3, v/v/v) or ethyl acetate in human and pig urine,
respectively [23,62]. In both cases, use of both targeted and
untargeted methods can be employed, however, some caution has
to be observed for the latter extraction if analysing by HRMS for
metabolites or potential biomarkers as some analytes had low re-
coveries in ethyl acetate at varying pH levels.
4.6. Dilute-and-shoot
In comparison to the aforementioned techniques bar LLE, DnS is
a generic analytical method with its advantages and disadvantages
outlined in Table 2. The evolution of DnS has facilitated the creation
of multi-analyte methods which were previously limited due to the
differing physiochemical properties of the analytes in question and
the sample clean-up technique chosen. One can note that with the
evolution of DnS to include foodstuffs, the initial solid-liquid
extraction can lead to SSE due to co-extraction of matrix, as well
as low recoveries of some of the target analytes based on the sol-
vent chosen and possible chemisorption. However, due to the
absence of stationary phase and chemistry therein, the technique is
considered not selective and permits the creation of multi-class,
multi-analyte methods. Although in comparison techniques such
as SPE, microextraction (SPME, SBSE and MEPS) and IAC can
generally achieve lower detection limits, they are hampered by
their respective selectivities and specificities, limiting the number
Table 2
Comparison of the various sample clean-up techniques employed in LC-MS, highlighting the main advantages and disadvantages of each and indicating their suitability for
multi-class, multi-analyte methods.
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multi-analyte methods, especially in pesticide analysis, but due to
the selectivity of the dSPE there is a limit to the number of different
classes incorporated in comparison to DnS. Furthermore, a recent
study by Steiner et al. (2020) analysed > 1200 biotoxins, pesticides
and veterinary drugs in complex feed using LC-MS/MS and
compared QuEChERS and DnS on their final extract. They concluded
that the QuEChERS approach showed limited improvement in
relation to matrix effects, whereas a straightforward 1:1 dilution
(DnS) of the sample extract gave the best results in regards to
reducing matrix effects and resulting method sensitivity [63]. This
indicates that although DnS dilutes rather than removes matrix
components in comparison to techniques such as SPE and QuECh-
ERS, it may not be inferior to these techniques. In the following
section, we will look at the application of DnS across various
matrices and scientific disciplines, detailing its evolution to allow
an increase in the number and class of analytes incorporated in a
single method.5. Dilute-and-shoot: applications
One of the main challenges in analytical chemistry is to strike a
compromise between matrix effects and method sensitivity. This is
where DnS can be extremely powerful, because it reduces matrix
effects and analyte exclusion, providing a platform for the creation
of multi-class, multi-analyte methods. Dilution of a sample or
extract can help abate matrix effects, depending on the dilution10factor, and higher dilution factors usually lead to an overall
reduction in method sensitivity. However, with little or no sample
workup there is massive potential for increased sample throughput
as well as lower solvent and consumable consumption.
Due to the lack of analyte selectivity afforded by DnS, use of LC-
MS/MS is usually preferred over LC-HRMS due to the increased
selectivity of the former. This is shown in Table 1 with examples of
DnS coupled to LC-MS/MS given across many different analyte
classes, disciplines andmatrices. In comparison, use of DnS coupled
to LC-HRMS has fewer examples as indicated in Table 1, with its use
mainly limited to the analysis of prescription drugs, DoA and sports
drugs in urine. Although the application of DnS coupled to QqQ
instruments is favourable, the MS platform is usually the limiting
factor in terms of the number of compounds that can be incorpo-
rated in one run. In this instance however, use of HRMS such as TOF,
Orbitrap or their quadrupole-hybrids can be considered a powerful
alternative [12]. It has been stated that use of DnS is more
commonly employed for low-complexity matrices and high-
abundance analytes, such as honey and wine [64], however,
below are examples of where DnS has been applied to complex
matrices.5.1. Urine, other biological fluids and liquid foodstuffs
With an increase in the number of drugs used to enhance
sporting performance and in use of both illicit and prescription
drugs, there is potential for laboratories to createmulti-class, multi-
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different screening procedures were utilised for analysis of
different drug classes including diuretics, beta-2-agonists, stimu-
lants and narcotics, whereas use of DnS coupled to sensitive MS
platforms has facilitated the development of a multi-method that
encompasses them in one analytical run [65]. Furthermore, due to
most xenobiotics undergoing phase II metabolism including glu-
curonidation and sulfonation, the presence of these metabolites
can act as indicators these compounds have been ingested, allow-
ing an increase in the detection window, especially beneficial for
drugs known to be metabolised quickly. DnS couples matrix
removal with minimal analyte losses to significantly improve urine
analyses, providing accurate and timely results.
An example of the efficacy in multi-class drug analysis is the
study by Guddat et al. (2011) looking at several drug classes,
covering more than 60 compounds in total with the fully validated
method permitting detection at levels lower than the required
limits. The group were also able to detect glucuronidated metab-
olites of a plasticiser commonly found in blood transfusion bags.
This enabled screening for these metabolites with their presence at
abnormally high levels indicating illegal use of blood transfusions
to enhance sporting performance, while avoiding the time-
consuming hydrolysis [65]. Another study by Dahlin et al. (2019)
analysed drugs used in clinical pain management including 37
clinically relevant prescription drugs, DoA and glucuronide me-
tabolites. The method employed a 1:10 dilution and was success-
fully validated to the Food and Drug Administration (FDA)
bioanalytical guidelines for 23 of the analytes, with the other 14
validated qualitatively [16]. Generally, clinical testing is routinely
performed by immunoassays (IAs) which are mainly considered as
screening or qualitative only. Although IAs give fast turnaround
times and are inexpensive when compared to LC-MS, they are less
sensitive, can give false negatives and most are not specific for a
particular drug but rather for broader drug classes. The simple
methodology embraces reduced testing costs and enhanced patient
care by allowing quick turnaround times, while also providing cli-
nicians with specific detection and quantification of multiple clin-
ically relevant analytes.
A study by Kong et al. (2017) used a DnS approach alongside LC-
MS/MS in the analysis of 113 DoA and their metabolites in human
urine. Their method required only 400 mL of sample and showed
minimal matrix effects, corrected for by use of isotopically-labelled
internal standards. However, this practice is not economically
viable for high numbers of analytes due to the prohibitive cost.
Their simple methodology was successfully applied in the identi-
fication and quantification of various DoA in 17 forensic urine
samples [66]. Another example is the analysis of the sports drug
higenamine and its metabolite by Gruzca et al. (2018). Apart from
improving the original methodology, another benefit was the
appearance of a second peak not present using the original meth-
odology. This peak was characterised as a sulfo-conjugate of
higenamine, an unknown metabolite which was indicated to last
longer than the native drug itself, aiding its detection [67]. Further
examples in the use of DnS in detection of these class of compounds
are the analysis of more than 80 DoA and sports drugs and the
analysis of more than 800 novel psychoactive substances (NPS),
both in human urine [5,30]. In the latter example by Alcantara-
Duran et al. (2018), they used a dilution factor of 1:50, five times
more than the usual dilution factor employed. This increase in
sensitivity was afforded by use of both nanoflow LC coupled to a Q-
Exactive Orbitrap HRMS, with nanoflow LC providing improved
ionisation efficiency. In the study by Kimble and DeCaprio (2019),
they improved on previous methodologies for detection of NPS in
biological matrices, with only a few methods capable of detecting
more than 100 in a single run and themajority detecting fewer than1150, with their methodology increasing the number to over 800
analytes.
Another field where the use of DnS with urine is utilised regu-
larly is the analysis of mycotoxins and their metabolites such as
glucuronides, sulphates, glutathione's, and other routes of bodily
detoxification. This has allowed scientists to explore toxicokinetics
and metabolism through biomarker studies, facilitating research
into understanding human and animal exposure to mycotoxins and
to investigate mitigation strategies. Biomarker-driven research has
been proposed as a successful method to assess exposure to xe-
nobiotics such as mycotoxins through analysis of both parent
compounds and metabolites in biological matrices such as urine.
Recent advances in MS detectors in both QqQ and HRMS platforms
have facilitated increased identification and quantification which
will help track chronic exposure to mycotoxins, with some listed as
carcinogenic and which are linked to some cancers [68,69]. Ex-
amples of these mycotoxin-biomarker studies include that con-
ducted by Gerding et al. (2015) investigating mycotoxin excretion
patterns across Bangladesh, Germany, and Haiti. They analysed 23
mycotoxins and metabolites in human urine using a 1:10 dilution
and LC-MS/MS [70]. This approach has also been used in several
studies conducted by Warth et al. (2012, 2013 and 2014) investi-
gating human exposure to mycotoxins through a multi-biomarker
approach, utilising the urinary excretion profile to ascertain expo-
sure. In all the aforementioned studies, urine was diluted 1:10 and
analysis performed using LC-MS/MS, with some studies looking at
several different mycotoxin classes [4,10,11,71]. There have also
been studies carried out in swine using the DnS approach as in
those conducted by Binder et al. (2017), whereby urine and faeces
were analysed after administration of ZEN and some of its ‘masked’
plant and fungal metabolites. Using a multi-biomarker approach
with a 1:10 dilution and LC-MS/MS analysis, they identified what
they considered ideal biomarkers to indicate chronic exposure of
animals to naturally-contaminated feed with ZEN [72]. A study by
Cao et al. (2018) developed a multi-mycotoxin LC-MS/MS method
for the simultaneous determination and quantitation of carcino-
genic mycotoxins in human biological fluids. In this instance, urine
was diluted approximately 1:4 (DnS) whereas plasmawas analysed
using a ‘dilute, evaporate and shoot’ approach [20]. As discussed in
the paper, the previous LOD using this approachwas considered too
high for most analytes (» 10 ng/mL), possibly due to the sensitivity
of the instrument employed. However, in this study the use of an
API 4500 MS (AB SCIEX) afforded LODs and LOQs of 0.03e0.41 ng/
mL and 0.11e1.0 ng/mL respectively in urine. This sensitive multi-
mycotoxin method could therefore be employed in monitoring
chronic exposure of mycotoxins in humans and in particular those
considered carcinogenic.
Another matrix that can simply be diluted for analysis is oral
fluid, especially applicable in the field of forensics, with one study
by Malaca et al. (2019) looking at psychoactive drugs such as
morphine, codeine, cocaine and D-9-tetrahydrocannabinol, with 13
analytes in total. The method required only 0.5 mL of sample and a
dilution factor of 1:3, with chromatographic separation taking only
6 min. The sample clean-up required 4 min, making the total
analysis time per sample 10 min [15]. Another study using OF was
conducted by Pichini et al. (2019) studying cannabinoids, their acid
precursors and some metabolites. The methodology required only
100 mL of sample with the validation parameters used indicating its
suitability for use in clinical trials in cannabis preparations [73].
Milk, and in particular bovine milk is another matrix that can
simply be diluted, although it requires an initial protein precipita-
tion step to prevent blocking the injector and/or chromatographic
components. Draher et al. (2016) investigated nitrogenous protein
adulterants with a dilution factor of 1:10. They compared DnS and
SPE and although found greater precision and accuracy with SPE,
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determination of these adulterants in routine lab analysis [74].
Furthermore, the US FDA developed a DnS methodology based on
that described by Mol et al. (2008) for the analysis of 30 veterinary
drugs in raw milk using HRMS in both ESIþ and ESI, with the
method then expanded to 76 compounds to include mycotoxins
and pesticides [75].
5.2. Animal feed and foodstuffs
Animal feed is an area that DnS has been heavily employed over
the last decade, in particular for mycotoxins with the number of
analytes in a single analysis increasing over time. This has in part
been due to the increased performance of MS platforms, with im-
provements in the systems electronics facilitating reductions in the
dwell, cycle and polarity switching times, allowing the inclusion of
more analytes. The application of DnS in this field first appeared in
2006 when Sulyok et al. (2006) used this methodology in the
analysis of 39 mycotoxins using LC-MS/MS and a dilution of 1:1
(v:v), although the paper did not refer to the technique as DnS. The
move to this generic sample clean-up technique was driven by a
desire to simultaneously analyse as many different classes of my-
cotoxins as possible in one run. However, with different classes
having differing physiochemical properties, the drawback was that
existing clean-up technologies such as SPE would result in losses or
incomplete recovery of some analytes. In order to circumvent this
but still reduce matrix effects, the group decided to simply dilute
the sample extract. This proved successful with negligible ion
suppression shown with wheat, however, significant ion suppres-
sionwas seen for approximately one third of analytes in maize. Due
to polarity switching not being fast enough at the time for the
number of analytes included, each sample was run twice, once in
positive ionisation mode (ESIþ) and once in negative ionisation
mode (ESI) [27]. In 2008, a study by Mols et al. extended it to 172
analytes, including pesticides, plant toxins, veterinary drugs and
mycotoxins. The technique used was slightly different to the
“mycotoxin multi-analyte method” employed by Sulyok et al.
(2006). Instead of diluting the final extract 1:1 (v/v), they per-
formed an initial extraction with water (5 mL) followed by dilution
by addition of 15 mL of acetonitrile giving an overall 1:4 dilution
factor [76].
In 2014, a study on the validation of a quantitative LC-MS/MS
method covering 295 bacterial and fungal metabolites including
all regulated mycotoxins was published by Malachova et al. (2014)
[28]. This study looked at four ‘model’ foodmatrices and how use of
DnS could be employed across each without the need for validating
individual food matrices. With 295 analytes validated, this was a
major step in the number incorporated in a single analytical run in
comparison to previous multi-methods published in the area
[77,78]. Of the four matrices investigated, the most complex (green
pepper) proved problematic with only 10% of analytes not suffering
from SSE and only 21% of the 295 analytes showed acceptable re-
coveries in the range of 70e120% as laid down by SANCO, leading to
the highest LOQs for the analytes involved. This highlighted some of
the issues with DnS when used with complex matrices with high
numbers of analytes suffering from SSE and poor recoveries of
some. A study by Sulyok et al. (2020) extended this approach
further by validating a DnS LC-MS/MS method for more than 500
mycotoxins and metabolites in seven different food matrices.
Employing DnS facilitated the analysis of multiple analytes in a
single method due to no other sample clean-up technique being
suitable for as many different classes of analytes with varying
physicochemical properties. Other examples where use of DnS in
foodstuffs has been successfully employed is in the analysis of rice
for both mycotoxins (10) and pesticides (6), or in the analysis of12mycotoxins (42) in cocoa beans [29,79]. One note on the latter
example is that although they used DnS, they also used a modified
form of QuEChERs to reduce co-extractives through addition of
sodium chloride. Although this method is not strictly DnS, it may
prove useful as the extra step was simply salt addition, adding little
to the cost or technicality with the advantage of reduced matrix
effects and increased method sensitivity.
In 2014 the group of Gomez-Perez et al. developed an LC-HRMS
multi-method for the simultaneous determination of veterinary
drug residues and pesticides in meat matrices using a DnS
approach, with more than 290 out of the target 350 analytes
meeting the desired recovery and precision values. Due to the fatty
nature of the matrix, further clean-up steps were employed,
including dSPE and SPE. However, the number of compounds with
an adequate recovery was less than when using DnS only and
therefore use of thesewas dropped [80]. In 2020, a study conducted
by Monteiro et al. developed a “mega-method” analysing veteri-
nary drug residues, pesticides and environmental contaminants in
beef by LC-MS/MS in tandem with GC-MS/MS, covering a total of
262 analytes. Regarding the LC-MS/MS sample analysis, the group
claimed a QuEChERS-based approach, however with no salts or
dSPE added in the extraction procedure, their methodology
equated to the expounded definition of DnS [81].
5.3. Other analytical areas and “omics” studies
Over the last 5 years, the use of DnS has been employed in the
detection of a wide range of analyses across many different scien-
tific disciplines. These include the analysis of drug seizures
permitting detection of the drug and the cutting or bulking agents
added. The previous methodology did not allow for the detection of
cutting agents or adulterants due to their physiochemical proper-
ties, however, switching to DnS alongside LC-HRMS allowed
detection of both [82]. It also has been used in the analysis of
honeybee venom (HBV), measurement of urinary neurotransmit-
ters and their metabolites to probe the pathology of several dis-
eases, identification of illegal insulin which use has led to lethal
incidents in the past, and in the detection of vesicant chemical
warfare agent metabolites in human urine as a monitoring or
screening tool [31,83e85].
Furthermore, there is the potential for the use of DnS for non-
targeted analysis or “omics” studies, such as metabolomics, either
using a targeted or untargeted approach. This is very much
dependant on the sample clean-up step taken prior to analysis,
with use of solid phase microextraction and/or extract and
concentrate both utilised. The use of solid phase microextraction in
sample preparation would lead to a ‘targeted’ metabolomics
approach due to the selectivity of the stationary phase, whereas the
latter technique, defined as “dilute, evaporate and shoot” being
more suitable for a fully untargeted metabolomics approach.
Depending on the matrix analysed, there may be the requirement
for an initial solid-liquid extraction, or deproteinisation step. In
either case, after addition of the solvent of choice and centrifuga-
tion, in most cases the resulting supernatant is evaporated to dry-
ness and reconstituted, usually in a smaller volume than the
original sample so as to concentrate the sample. This is preferred so
as not to dilute the global profile of analytes/metabolites present,
with the concentrations of analytes expected not at high enough
levels for an untargeted approach. This is also in part due to the lack
of selectivity afforded by HRMS instruments and the fact that a
complete profile is sought rather than a targeted class of analytes.
This approach can be defined as “dilute, evaporate and shoot”, with
the methodology employed in most cases for biological matrices
such as blood (serum/plasma) and urine. This “dilute, evaporate
and shoot” approach has been used in biomarker discovery in
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spectral library's from urine samples [86e88], whereas a straight-
forward DnS approach has been employed in the analysis of fresh
orange juice to study chemical contaminants [89]. The “dilute,
shoot and evaporate” approach is in essence very similar to DnS and
has been a powerful tool for metabolomics approaches across
various foodstuffs in determining contaminants, as well as in food
safety and quality analyses, with examples covered in reviews by Li
et al. (2020) and Lopez-Ruiz et al. (2019) [90,91].6. Conclusions and future trends
DnS is a less expensive and more environmentally-friendly
sample clean-up technique that facilitates high sample
throughput. The evolution and application of DnS in analytical
chemistry has allowed it to be used across various scientific
research applications. An optimal practiceworkflow for the “dilute-
and-shoot” approach is indicated in Fig. 1 for the main matrices
covered in this review, and has been extended to include the
“dilute, evaporate and shoot” approach for the analysis of blood.
This is a proposed best practice workflow based on the literature
surveyed and is very much dependent on the sensitivity re-
quirements of the methods and MS platforms available. With
newer hybrid HRMS systems, there is the ability to carry out both
qualitative (screening) and quantitative analysis in the same run.
Furthermore, samples could be qualitatively analysed by LC-HRMS
and any potential ‘hits’ quantified on LC-MS/MS, allowing users to
identify specific contaminants/adulterants and therefore decide
which targeted methodology should be employed. It also allows
retrospective data analysis for emerging threats with the knowl-
edge that a global profile of analytes should be present due to
minimal analyte losses due to use of DnS as the sample clean-up.
Dilution of the final extract reduces matrix effects and subse-
quently increases LOQs, but this can vary depending on the analyte/
matrix combination. There does not appear to be a linear rela-
tionship between the dilution factor applied and towhat extent the
LOQ will increase. With that in mind and with a wide range of
dilution factors employed, usually between 2 and 50, it is difficult to
predict what dilution factor should be used for other analytes in
varying matrices and therefore if DnS can in fact be used [36].
However, from the literature surveyed, 1:2 and 1:10 appear to be
the dilution factor of choice more often than not for feed and urine
studies respectively. The trade-off in not achieving LOQs as low as
when using more selective sample clean-up techniques is the
benefit in building multi-methods which can include many analy-
tes over many different classes, with the number of analytes
increasing year on year. A recent example of the increasing number
is the analysis of >1200 biotoxins, including fungal metabolites,
pesticides, veterinary drugs, plant toxins and bacterial metabolites
by Steiner et al. (2020). They analysed a sample extract using a 1:1
dilution, which gave the best results in regards to matrix effects
reduction and resultingmethod sensitivity. This example highlights
how employing the expounded definition of DnS can be used in the
future to create multi methods that cover a wide variety of analyte
classes. A further example of the future application of DnS is in
creation of methods for mixed organic chemical residues and
contaminants to encompass as many different residues, metabo-
lites of and contaminants [75]. These multi-methods can poten-
tially be extended to include natural toxins such as mycotoxins,
phytotoxins such as pyrrolizidine alkaloids, freshwater toxins,
contaminants including pesticides, veterinary drug residues and
toxins produced during food processing and packaging. One of the
challenges of increasing analyte number is that method13performance drops in terms of the number of data points across
each peak and therefore the subsequent loss in reliable, robust data
for accurate quantification and validation. This is due to the
increased number of MRM transitions required within a particular
retention window, with cycle and dwell times, as well as polarity
switching having to be taken into consideration in order to acquire
enough data points per analyte. These factors eventually limit the
number of analytes assayed in one run when using QqQ in-
struments for accurate quantification. This can be improved by use
of HPLC columns with 5 mm particle size as opposed to UHPLC
columns with sub 2-mm particle size, which although give broader
peaks, allow more data points per peak, yet which also increases
analysis run time, as well as running the samples twice in both ESIþ
and ESI mode [3,63].
Multi methods could also be adopted in place of several single-
class methods and could be applied to clinical or forensic toxicology
where “drugs of abuse” (DoA) can be combined into one multi-
method including those that are illegal, both naturally occurring
and synthetic, alongside therapeutic drugs which can bemisused for
recreational purposes. In this instance, a strict DnS approach of urine
could be employed, although depending on the levels of the parent
present and how quick they are metabolised, sensitivity may be an
issue. Nonetheless, use of LC-HRMSwithDnS forDoA, especiallywith
the improvements inanalytical capabilitiesofHRMS instrumentsmay
bemore beneficial due to being able to retrospectively check the data
produced for new and emerging drugs.
There are also limits to the use of DnS in that some methods
such as pesticide residue analysis in fruit and vegetables already
have established, validated methodologies and there is no point in
trying to modify these well-established, validated and accredited
procedures. However, methods such as this could be extended to
include other contaminants such as mycotoxins, veterinary drugs
and antibiotics, with a switch from QuEChERs to DnS facilitating
this without the laborious method development that would nor-
mally be required, with an example of the study carried out by
Martinez-Dominguez et al. (2016), with screening and quantitation
afforded by use of LC-HRMS. Although DnS has been successfully
employed in numerous research fields, there is the potential for its
scope to be widened if nanoflow LC was routinely incorporated in
some cases alongside MS detection. This would potentially permit
further reductions in matrix effects by facilitating further dilution
of the sample while still enabling analysis of analytes at low levels
in complex matrices that may not have been possible before unless
specific, selective techniques such as SPE or IAC were employed.
Therefore, as the frontiers of LC-MS platforms continue to evolve
resulting in instruments with increased resolution, selectivity and
sensitivity, the use of dilute-and-shoot has and will continue to
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